NCT03612466 A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy Status WITHDRAWN Phase PHASE1
NCT03496402 Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) Status ACTIVE_NOT_RECRUITING Phase NA
NCT03478462 Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03458728 Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients Status TERMINATED Phase PHASE1/PHASE2
NCT03442465 Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas Status RECRUITING Phase N/A
NCT03422679 Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT03390946 Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma Status UNKNOWN Phase PHASE2
NCT03373097 Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03358628 Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma Status UNKNOWN Phase N/A
NCT03242382 Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. Status RECRUITING Phase PHASE2
NCT03220035 Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) Status COMPLETED Phase PHASE2
NCT03209869 Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2 Status WITHDRAWN Phase PHASE1
NCT03206450 Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors Status COMPLETED Phase N/A
NCT03108677 Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03063983 Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma Status UNKNOWN Phase PHASE2
NCT03013127 A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery Status TERMINATED Phase PHASE2
NCT03006848 A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma Status COMPLETED Phase PHASE2